SPONSOR
University Medical Center Groningen
Total Trials
15
Recruiting
15
Phases
Phase 2, Phase 2, Phase 3, Phase 1, Phase 2
Conditions studied: Virtual RealityOncological PatientsTyrosine Kinase InhibitorPsychiatric DisordersCKDCardiovascular DiseasesHeart FailureAtrial Fibrillation RecurrentCervical Cancer Radiation ComplicationsHuntington Disease
University Medical Center Groningen is a clinical research sponsor with 15 registered studies on ClinicalTrials.gov, of which 15 are actively recruiting participants. Research covers conditions including Virtual Reality, Oncological Patients, Tyrosine Kinase Inhibitor, Psychiatric Disorders.
The trial portfolio spans Phase 2, Phase 2, Phase 3, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University Medical Center Groningen
How many clinical trials has University Medical Center Groningen sponsored?
ClinicalMetric currently tracks 15 clinical trials sponsored by University Medical Center Groningen, of which 15 are actively recruiting participants. These trials cover conditions including Virtual Reality, Oncological Patients, Tyrosine Kinase Inhibitor. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University Medical Center Groningen research focus on?
University Medical Center Groningen clinical trials span Virtual Reality, Oncological Patients, Tyrosine Kinase Inhibitor, Psychiatric Disorders, CKD, and additional conditions. The research pipeline includes Phase 2, Phase 2, Phase 3, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University Medical Center Groningen clinical trial?
To participate in a University Medical Center Groningen trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Medical Center Groningen trials with current recruitment status updated daily.
Clinical Trials by University Medical Center Groningen
NCT05440825
Recruiting
Self-management of Stress and Sleep Disturbances with Virtual Reality Relaxation
Virtual Reality
NCT07258589
Recruiting
The TASTY-training Study
Oncological Patients
NCT07373223
Recruiting
Virtual Reality Schema Therapy Exercises With Parent and Child Modes
Psychiatric Disorders
NCT07304817 Phase 2
Recruiting
Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)
CKD
NCT06199180
Recruiting
Pulsed Field Ablation Versus Conventional Radiofrequency Catheter Ablation for Repeat PVI in Patients With Paroxysmal AF
Atrial Fibrillation Recurrent
NCT02733289
Recruiting
Standard Follow-up Program Cervix Cancer (SFP CERVIX)
Cervical Cancer Radiation Complications
NCT06774443
Recruiting
Hinting Task for Huntington's Disease
Huntington Disease
NCT05864794
Recruiting
Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer
Non Small Cell Lung Cancer Metastatic
NCT07606014 Phase 2, Phase 3
Recruiting
No Guts No Glory Probiotics
Patients Using Olanzapine, Quetiapine, Risperidone or Clozapine
NCT07585890
Recruiting
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
End-stage Liver Disease (ESLD)
NCT07108855 Phase 1, Phase 2
Recruiting
Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine Green During Endoscopic Submucosal Dissection
Esophageal Carcinoma
NCT05076942 Phase 2
Recruiting
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
Vulvar Cancer
NCT06484491
Recruiting
IMPT Dose Escalation for NSCLC (HyDose)
Carcinoma, Non-Small-Cell Lung
NCT07258563
Recruiting
The TASTY-steering Study
Metastatic Triple Negative Breast Cancer
NCT07206017
Recruiting
Explorative Study on Addition of High-fiber Dried Chicory Root in Patients With an Intermediate to High-risk Cutaneous Melanoma.
Melanoma, Stage II
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology